Literature DB >> 20724660

Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense.

Kei-ichiro Arimoto1, Kenji Funami, Yasushi Saeki, Keiji Tanaka, Katsuya Okawa, Osamu Takeuchi, Shizuo Akira, Yoshiki Murakami, Kunitada Shimotohno.   

Abstract

The rapid induction of type I IFN is a central event of the innate defense against viral infections and is tightly regulated by a number of cellular molecules. Viral components induce strong type I IFN responses through the activation of toll-like receptors (TLRs) and intracellular cytoplasmic receptors such as an RNA helicase RIG-I and/or MDA5. According to recent studies, the NF-kappaB essential modulator (NEMO, also called IKKgamma) is crucial for this virus-induced antiviral response. However, the precise roles of signal activation by NEMO adaptor have not been elucidated. Here, we show that virus-induced IRF3 and NF-kappaB activation depends on the K(lys)-27-linked polyubiquitination to NEMO by the novel ubiquitin E3 ligase triparite motif protein 23 (TRIM23). Virus-induced IRF3 and NF-kappaB activation, as well as K27-linked NEMO polyubiquitination, were abrogated in TRIM23 knockdown cells, whereas TRIM23 knockdown had no effect on TNFalpha-mediated NF-kappaB activation. Furthermore, in NEMO-deficient mouse embryo fibroblast cells, IFN-stimulated response element-driven reporter activity was restored by ectopic expression of WT NEMO, as expected, but only partial recovery by NEMO K165/309/325/326/344R multipoints mutant on which TRIM23-mediated ubiquitin conjugation was substantially reduced. Thus, we conclude that TRIM23-mediated ubiquitin conjugation to NEMO is essential for TLR3- and RIG-I/MDA5-mediated antiviral innate and inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724660      PMCID: PMC2936632          DOI: 10.1073/pnas.1004621107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Finding NEMO by K63-linked polyubiquitin chain.

Authors:  F Chen; D Bhatia; Q Chang; V Castranova
Journal:  Cell Death Differ       Date:  2006-07-21       Impact factor: 15.828

2.  Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.

Authors:  Supriya K Saha; Eric M Pietras; Jeannie Q He; Jason R Kang; Su-Yang Liu; Gagik Oganesyan; Arash Shahangian; Brian Zarnegar; Travis L Shiba; Yao Wang; Genhong Cheng
Journal:  EMBO J       Date:  2006-07-06       Impact factor: 11.598

Review 3.  Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.

Authors:  Kenya Honda; Akinori Takaoka; Tadatsugu Taniguchi
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

4.  The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.

Authors:  Tiejun Zhao; Long Yang; Qiang Sun; Meztli Arguello; Dean W Ballard; John Hiscott; Rongtuan Lin
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

5.  DUBA: a deubiquitinase that regulates type I interferon production.

Authors:  Nobuhiko Kayagaki; Qui Phung; Salina Chan; Ruchir Chaudhari; Casey Quan; Karen M O'Rourke; Michael Eby; Eric Pietras; Genhong Cheng; J Fernando Bazan; Zemin Zhang; David Arnott; Vishva M Dixit
Journal:  Science       Date:  2007-11-08       Impact factor: 47.728

6.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.

Authors:  Michaela U Gack; Young C Shin; Chul-Hyun Joo; Tomohiko Urano; Chengyu Liang; Lijun Sun; Osamu Takeuchi; Shizuo Akira; Zhijian Chen; Satoshi Inoue; Jae U Jung
Journal:  Nature       Date:  2007-04-19       Impact factor: 49.962

7.  Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo.

Authors:  Chang-Yuan Ni; Zhao-Hui Wu; William C Florence; Vrajesh V Parekh; Maria Pia Arrate; Steven Pierce; Brock Schweitzer; Luc Van Kaer; Sebastian Joyce; Shigeki Miyamoto; Dean W Ballard; Eugene M Oltz
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

8.  Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.

Authors:  Derek W Abbott; Yibin Yang; Jessica E Hutti; Swetha Madhavarapu; Michelle A Kelliher; Lewis C Cantley
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

9.  PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit.

Authors:  Takashi Tanaka; Michael J Grusby; Tsuneyasu Kaisho
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

10.  Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.

Authors:  Kei-ichiro Arimoto; Hitoshi Takahashi; Takayuki Hishiki; Hideyuki Konishi; Takashi Fujita; Kunitada Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-25       Impact factor: 11.205

View more
  85 in total

1.  Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation.

Authors:  Zhifang Cao; Kara L Conway; Robert J Heath; Jason S Rush; Elizaveta S Leshchiner; Zaida G Ramirez-Ortiz; Natalia B Nedelsky; Hailiang Huang; Aylwin Ng; Agnès Gardet; Shih-Chin Cheng; Alykhan F Shamji; John D Rioux; Cisca Wijmenga; Mihai G Netea; Terry K Means; Mark J Daly; Ramnik J Xavier
Journal:  Immunity       Date:  2015-10-20       Impact factor: 31.745

Review 2.  Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease.

Authors:  Xuetao Cao
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

3.  TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1.

Authors:  Yunfei Qin; Qingxiang Liu; Shuo Tian; Weihong Xie; Jun Cui; Rong-Fu Wang
Journal:  Cell Res       Date:  2016-02-26       Impact factor: 25.617

4.  Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.

Authors:  Yuan Wang; Lei Cui; Guifang Yang; Jianbo Zhan; Liang Guo; Yu Chen; Chengpeng Fan; Dan Liu; Deyin Guo
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

5.  Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO.

Authors:  Juan Liu; Chaofeng Han; Bin Xie; Yue Wu; Shuxun Liu; Kun Chen; Meng Xia; Yuan Zhang; Lijun Song; Zhiqing Li; Ting Zhang; Feng Ma; Qingqing Wang; Jianli Wang; Kejing Deng; Yuan Zhuang; Xiaohui Wu; Yizhi Yu; Tian Xu; Xuetao Cao
Journal:  Nat Immunol       Date:  2014-05-25       Impact factor: 25.606

6.  Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?

Authors:  Caroline Jefferies; Claire Wynne; Rowan Higgs
Journal:  Nat Rev Immunol       Date:  2011-08-25       Impact factor: 53.106

7.  The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors.

Authors:  Gijs A Versteeg; Ricardo Rajsbaum; Maria Teresa Sánchez-Aparicio; Ana M Maestre; Julio Valdiviezo; Mude Shi; Kyung-Soo Inn; Ana Fernandez-Sesma; Jae Jung; Adolfo García-Sastre
Journal:  Immunity       Date:  2013-02-21       Impact factor: 31.745

8.  Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.

Authors:  Nicole Arnold; Christine Meyer; Flora Engelmann; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2017-03-20       Impact factor: 2.643

9.  Molluscum Contagiosum Virus MC159 Abrogates cIAP1-NEMO Interactions and Inhibits NEMO Polyubiquitination.

Authors:  Sunetra Biswas; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

10.  Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract.

Authors:  Junji Xing; Leiyun Weng; Bin Yuan; Zhuo Wang; Li Jia; Rui Jin; Hongbo Lu; Xian Chang Li; Yong-Jun Liu; Zhiqiang Zhang
Journal:  Nat Immunol       Date:  2016-10-03       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.